team banner.jpg

  Hanadie Yousef is a trained stem cell biologist and neurobiologist with a focus on the mechanisms of aging, with pending and issued patents, several publications, a BS from Carnegie Mellon University (CMU), a PhD from UC Berkeley, a 4-year postdoctoral fellowship at Stanford School of Medicine, experience leading research teams, and has worked in R&D at  Regeneron and Genentech.    Yousef began doing biomedical research at the age of 16, when she interned locally at a pharmaceutical company in New York where she grew up, Regeneron, to conduct research on gene therapy and cancer. It was at this time that Yousef fell in love with drug discovery and development and knew she wanted to dedicate the rest of her life to this pursuit. She skipped a grade and attended CMU to study chemistry and continue her passion in scientific research. She returned to Regeneron to continue her research during winter and summer internships for 5 years (2003-2008). During her undergraduate studies at CMU, Yousef did a research honors thesis in the Kaminski lab at the University of Pittsburgh Medical Center, where she elucidated molecular mechanisms driving idiopathic pulmonary lung fibrosis.    In graduate school in the Schaffer and Conboy labs at UC Berkeley (2008-2013),  Dr.  Yousef studied the role of adult stem cells in the biology of aging and developed methods for tissue rejuvenation in brain and muscle. She published 4 first-author papers, a research perspective,and has an issued patent and a patent application based on her discoveries.

JOE WU, MD, PHD
ADVISORY BOARD MEMBER

Joseph C. Wu, MD, PhD is Director of the Stanford Cardiovascular Institute and Simon H. Stertzer Endowed Professor in Department of Medicine (Cardiology) and Department of Radiology at the Stanford School of Medicine.

In addition, he is Co-Founder of Stem Cell Theranostics, a biotechnology company dedicated to accelerating therapeutic discovery and enabling personalized medicine using patient-derived cell models.

At Stanford, his lab works on biological mechanisms of patient-specific and disease-specific induced pluripotent stem cells (iPSCs).

sms logo.png
stemcellTheranostics.jpeg